In the superheated market for batteries, promising lab developments often get overhyped by startups. ‘Liar, liar, battery supplier.’
DNAlite Therapeutics, Inc., an early stage preclinical therapeutic company has raised $1.5 million in a seed-stage financing. DNAlite was founded by U
